RXI Pharma Cash Flow - Quarterly (NASDAQ:RXII)

Add to My Stocks
$1.2 $0.02 (1.64%) RXII stock closing price Sep 21, 2018 (Closing)

The RXI Pharma cash flow statement helps investors understand how well the company is managing its cash flows. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For RXI Pharma profits one has to check the income statement and for RXI Pharma debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in RXI Pharma stock analysis. RXI Pharma had a negative net income cash flow of $-4.14M till this quarter of 2018 Q2. This report is very useful in measuring the short term viability of a company. RXII decrease in investments stood at a value of $- for the latest quarter 2018 Q2.

View and download details of RXI Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Net Income Cash Flow
-4.14M-2.23M-12.45M-10.45M-7.97M-5.46M-8.99M-6.65M-4.44M-2.23M
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities---0.53M-0.26M-0.47M-0.45M--0.41M-0.88M-1M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--3.39M3.35M3.3M3.1M----
Net Cash from (used by) Operating Activities
-3.76M-1.9M-9.51M-7.31M-5.11M-2.79M-7.76M-6.38M-4.78M-2.92M
Increase (Decrease) in Prop Plant And Equipment---0.2M-0.2M-0.18M-----
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments------5.5M3.5M3.5M2M
Other Cash Inflow (Outflow) from Investment Activities-------0.15M---
Net Cash from (used by) Investment Activities
---0.1M-0.1M-0.08M-5.34M3.49M3.5M2M
Issuance (Purchase) of Equity Shares5.5M---0.07M--10.2M---
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
5.5M---0.07M--10.2M---
Effect of Exchange Rate Changes on Cash----------
Net Change in Cash & Cash Equivalents
1.73M-0.97M-9.32M-7.49M-5.2M-2.7M7.78M-2.73M-1.28M-0.92M
Cash & Equivalents at Beginning of Year12.95M5.11M8.49M11.39M5.12M-6.89M6.89M--
Cash & Equivalents at Year End5.36M2.65M3.63M5.46M7.75M10.25M12.9M2.37M3.83M4.19M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The RXI Pharma stock price history and RXI Pharma stock comparison chart inevitably reflect its cash flow situation.

  • RXI Pharma has cash of $5.36M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the RXI Pharma stock price.
  • RXI Pharma decreased its cash from operating activities to $-3.76M till 2018 Q2. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $- for RXII stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $5.5M for RXI Pharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For RXI Pharma Cash Flow